CPT 96372: Intramuscular or Subcutaneous Therapeutic Injection
Medicare pays $16 and commercial payers pay $48 on average nationally for this procedure.
CPT code 96372 describes a therapeutic, prophylactic, or diagnostic substance administered by intramuscular or subcutaneous injection by a physician or under direct physician supervision; this is an injection procedure typically performed in outpatient clinic, office, or ambulatory care settings for single-drug administration (vaccines and toxoids are excluded).
For related coverage guidance, see recent payer policy updates: Percutaneous Electrical Nerve Field Stimulation for Functional Abdominal Pain Disorders, Esophagogastroduodenoscopy (EGD) Coverage Policy, Radiofrequency Therapy for Fecal Incontinence.
Customize your policy alerts
Sign up for cpt 96372 policy alerts
Get alerted when payer policies referencing 96372 are released or updated.
Monitor payer policy activity
National Reimbursement Benchmarks
Across national payers, Medicare's average reimbursement for CPT 96372 sits at $15.9, substantially below BUCA’s mean commercial level of $48.4, underscoring a sizable gulf between Medicare and average commercial pricing. This gap reflects Medicare’s more constrained mean compared with commercial plans, with BUCA roughly three times higher than Medicare on average.
Dispersion (P75 minus P25) varies meaningfully: Aetna shows a spread of $35.0, Blue Cross Blue Shield a spread of $39.4, BUCA a spread of $29.3, Cigna a spread of $18.1, Medicare a tight spread of $1.0, and UnitedHealth Group a spread of $15.2. Blue Cross Blue Shield exhibits the widest interquartile range, while Medicare is the tightest; Cigna and UnitedHealth Group are also relatively narrow compared with Aetna and BUCA.